The veteran's claimed conditions were not incurred or aggravated by service, and there is no evidence of a nexus between the disabilities and his military service. The Board denied both claims for service connection.
The deciding factor: There was no medical evidence linking the veteran's claimed conditions to his military service, including exposure to herbicides in Vietnam.
- Claimed conditions
- gastroesophageal adenocarcinoma, reflex sympathetic dystrophy of both lower extremities
- How they argued it
- Presumptive (no nexus needed)
- Exposure basis
- None
- Rating assigned
- None in this decision
- Decision date
- April 6, 2006
- Citation
- 0610011
What this means for you
A denial is a starting point, not the end of the road. You can see why this claim fell short — and, if you are still inside the one-year window, the appeal lanes that may remain open to you.
What you can do next
Related decisions
Other Board decisions on a similar condition or argued the same way.
- Remanded (sent back)
The Board remands the claim for service connection for gastroesophageal adenocarcinoma to obtain a new VA medical opinion that adequately addresses the Veteran's assertions of herbicide exposure during his Vietnam-era service.
- Remanded (sent back)
The Board remands the claim for a medical opinion addressing whether the Veteran's left eye condition is related to service, as it found that the condition did not preexist service.
- Granted
The Board granted service connection for prostate cancer, related to in-service exposures at Camp Lejeune.
- Granted
The Veteran is granted an effective date of August 10, 2022, for the grant of service connection for sinusitis based on the PACT Act.
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.